ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

2,65
-0,01
(-0,38%)
Geschlossen 20 Januar 10:00PM
2,65
0,00
(0,00%)
Nach Börsenschluss: 11:16PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
2,65
Gebot
2,45
Fragen
2,81
Volumen
28.110
2,61 Tagesbereich 2,75
2,44 52-Wochen-Bereich 9,374
Marktkapitalisierung
Handelsende
2,66
Handelsbeginn
2,62
Letzte Trade
164
@
2.65
Letzter Handelszeitpunkt
Finanzvolumen
US$ 75.367
VWAP
2,6811
Durchschnittliches Volumen (3 Mio.)
312.123
Ausgegebene Aktien
1.339.170
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,73
Gewinn pro Aktie (EPS)
-3,61
Erlöse
12,74M
Nettogewinn
-4,84M

Über Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of ther... Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Sonoma Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNOA. The last closing price for Sonoma Pharmaceuticals was US$2,66. Over the last year, Sonoma Pharmaceuticals shares have traded in a share price range of US$ 2,44 to US$ 9,374.

Sonoma Pharmaceuticals currently has 1.339.170 shares in issue. The market capitalisation of Sonoma Pharmaceuticals is US$3,56 million. Sonoma Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.73.

SNOA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.031.145038167942.622.742.52349672.62233616CS
40.083.112840466932.572.8452.52415632.67455734CS
12-0.42-13.6807817593.073.52.443121232.97123397CS
26-5.75-68.45238095248.492.446520374.88151872CS
52-1.026-27.91077257893.6769.3742.4419169574.57840781CS
156-87.35-97.05555555569091.82.318115028718.08805644CS
260-97.35-97.35100390.82.31898677961.76264296CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals share price?
The current share price of Sonoma Pharmaceuticals is US$ 2,65
How many Sonoma Pharmaceuticals shares are in issue?
Sonoma Pharmaceuticals has 1.339.170 shares in issue
What is the market cap of Sonoma Pharmaceuticals?
The market capitalisation of Sonoma Pharmaceuticals is USD 3,56M
What is the 1 year trading range for Sonoma Pharmaceuticals share price?
Sonoma Pharmaceuticals has traded in the range of US$ 2,44 to US$ 9,374 during the past year
What is the PE ratio of Sonoma Pharmaceuticals?
The price to earnings ratio of Sonoma Pharmaceuticals is -0,73
What is the cash to sales ratio of Sonoma Pharmaceuticals?
The cash to sales ratio of Sonoma Pharmaceuticals is 0,28
What is the reporting currency for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Sonoma Pharmaceuticals?
The latest annual turnover of Sonoma Pharmaceuticals is USD 12,74M
What is the latest annual profit for Sonoma Pharmaceuticals?
The latest annual profit of Sonoma Pharmaceuticals is USD -4,84M
What is the registered address of Sonoma Pharmaceuticals?
The registered address for Sonoma Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Sonoma Pharmaceuticals website address?
The website address for Sonoma Pharmaceuticals is www.sonomapharma.com
Which industry sector does Sonoma Pharmaceuticals operate in?
Sonoma Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock